Deborah Leatha Hardy, CRNA | |
19521 Caney Ave, Carson, CA 90746-2418 | |
(310) 608-0331 | |
(310) 635-1340 |
Full Name | Deborah Leatha Hardy |
---|---|
Gender | Female |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 19521 Caney Ave, Carson, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760573406 | NPI | - | NPPES |
RN2337980 | Other | CA | MEDI-CAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 536 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Deborah Leatha Hardy, CRNA 19521 Caney Ave, Carson, CA 90746-2418 Ph: (310) 608-0331 | Deborah Leatha Hardy, CRNA 19521 Caney Ave, Carson, CA 90746-2418 Ph: (310) 608-0331 |
News Archive
Researchers have developed a new tool to catalog police and law enforcement interactions with black men, the Police and Law Enforcement Scale, with the hope of documenting people's experiences and perceptions of police-based discrimination.
Finding out if the food and water we consume are safe from toxic and carcinogenic metals can now be much faster and simpler.
Researchers from the 'Angiogenesis signaling pathways' research group of the Institute of Biomedical Investigation of Bellvitge, led by Dr. Mariona Graupera, have unveiled the potential therapeutic benefit of a selective inhibitior of the PI3-kinase (PI3K) protein in pancreatic neuroendocrine tumors (PanNETs).
A new study has shown there is an urgent need for more children to take part in clinical trials to make sure medicines can be licensed for their safe and effective use.
The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018.
› Verified 3 days ago